Modulation of inflammatory gene transcripts in psoriasis vulgaris: Differences between ustekinumab and etanercept

J Allergy Clin Immunol. 2019 May;143(5):1965-1969. doi: 10.1016/j.jaci.2019.01.017. Epub 2019 Jan 29.
No abstract available

Publication types

  • Clinical Trial, Phase III
  • Letter
  • Multicenter Study
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use*
  • Dermatologic Agents / therapeutic use*
  • Double-Blind Method
  • Etanercept / therapeutic use*
  • Humans
  • Psoriasis / drug therapy*
  • Psoriasis / genetics*
  • Skin / metabolism
  • Transcriptome / drug effects*
  • Ustekinumab / therapeutic use*

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Dermatologic Agents
  • Ustekinumab
  • Etanercept